Understanding and overcoming barriers to human papillomavirus vaccine acceptance

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.

Original languageEnglish
JournalCurrent Opinion in Obstetrics and Gynecology
Volume18
Issue numberSUPPL. 1
DOIs
StatePublished - Feb 2006

Fingerprint

Papillomavirus Vaccines
Vaccines
Parents
Vaccination
Sexually Transmitted Diseases
Patient Care
Delivery of Health Care
Physicians
Papanicolaou Test
Papillomavirus Infections
Nuclear Family
Psychological Stress
Uterine Cervical Neoplasms
Health Personnel
Communication
Observation
Incidence

Keywords

  • Cervical cancer
  • Genital warts
  • Human papillomavirus (HPV)
  • Vaccines

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Understanding and overcoming barriers to human papillomavirus vaccine acceptance. / Zimet, Gregory.

In: Current Opinion in Obstetrics and Gynecology, Vol. 18, No. SUPPL. 1, 02.2006.

Research output: Contribution to journalArticle

@article{70da86dca9564df28af21c1c4d63e053,
title = "Understanding and overcoming barriers to human papillomavirus vaccine acceptance",
abstract = "New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.",
keywords = "Cervical cancer, Genital warts, Human papillomavirus (HPV), Vaccines",
author = "Gregory Zimet",
year = "2006",
month = "2",
doi = "10.1097/01.gco.0000216317.10690.8f",
language = "English",
volume = "18",
journal = "Current Opinion in Obstetrics and Gynecology",
issn = "1040-872X",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Understanding and overcoming barriers to human papillomavirus vaccine acceptance

AU - Zimet, Gregory

PY - 2006/2

Y1 - 2006/2

N2 - New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.

AB - New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.

KW - Cervical cancer

KW - Genital warts

KW - Human papillomavirus (HPV)

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=33746426005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746426005&partnerID=8YFLogxK

U2 - 10.1097/01.gco.0000216317.10690.8f

DO - 10.1097/01.gco.0000216317.10690.8f

M3 - Article

C2 - 16520681

AN - SCOPUS:33746426005

VL - 18

JO - Current Opinion in Obstetrics and Gynecology

JF - Current Opinion in Obstetrics and Gynecology

SN - 1040-872X

IS - SUPPL. 1

ER -